FDA Inspection 1024102 — Octapharma Plasma Inc.
The FDA completed an inspection of Octapharma Plasma Inc. on August 24, 2017 in Columbus, OH. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 24, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Columbus, OH (United States)